Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Smith & Nephew, Inc.234 enrolled

Overview

The purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rotator cuff tears.

The primary objective of this study is to evaluate the functional recovery of patients with high grade (\>50%) partial thickness tears at 3 months when treated with either Isolated Bioinductive Repair (IBR) or Completion and Repair (CAR).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

234

Conditions

Rotator Cuff Injuries

Interventions

Isolated Bioinductive RepairDEVICE

Isolated Bioinductive repair with REGENETEN™ Bioinductive Implant

Completion and RepairPROCEDURE

Standard surgical repair using the 'Completion and Repair' technique.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The subject must provide written informed consent. * Subject is \> eighteen (18) years of age (no upper limit). * Subject has an isolated high-grade (\>50% or \>6mm) (Ellman grade III) partial thickness tear of supraspinatus or supraspinatus with infraspinatus. * Subject has failed a minimum of 3 months of conservative management for treatment of partial thickness rotator cuff tear. * Subject willing and able to make all required study visits. * Subject able to follow instructions and deemed capable of completing all study questionnaires. Exclusion Criteria: * Subjects with insufficient tendon tissue quality for management and protection of the tendon injury using the isolated REGENETEN Bioinductive Implant system. * Subjects where the prescribed Physical Therapy guidelines stated in the protocol are not suitable for their rehabilitation. * Subjects with Samilson-Prieto osteoarthritis grade 2 and greater. * Subjects with current or prior infection of the ipsilateral shoulder. * Subjects with known hypersensitivity to bovine-derived materials. * Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, chronic joint disease or chronic pain of upper extremities (shoulder(s), arm(s)). * Subjects with prior shoulder surgery on index shoulder, including subacromial decompression, biceps tenodesis/tenotomy, and acromioclavicular joint (ACJ) excision/distal clavicle excision (DCE). * Subjects with a planned surgery on the contra-lateral shoulder within the study period. * Systemic steroid use (oral, IV) or local steroid injection within 3 months of the date of surgery. * Subjects with a full thickness rotator cuff tear. * Subjects with a subscapularis tear requiring repair. * Subjects requiring a concomitant labral fixation procedure, concomitant surgery for bone defects requiring bone implantation or for superior labral tear from anterior to posterior (SLAP). * Subjects requiring a concomitant os acromiale fixation procedure. * Subjects with glenohumeral joint instability (multiple dislocations/subluxations). * Subjects with condition(s) that contraindicate or complicate outcomes of Isolated Bioinductive Repair or completion and repair e.g., \> Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy \> Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head. * Subjects with neurologic conditions effecting either upper extremity. * Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications. * Subjects who are pregnant or breast feeding. * Subjects who are currently involved in any injury litigation relating to the index shoulder. * Subjects with current workers compensation claim. * Subjects who are enrolled, or plan to enroll, in another clinical trial during this study that would affect the outcomes of this study. * Subjects with a history of poor compliance with medical treatment, physical therapy (PT)/rehabilitation, or clinical study participation. * Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, and drug or alcohol abuse. * Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs). * Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.55. * Subjects who have participated previously in this clinical trial and who have healed or been withdrawn * Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Locations (20)

Harbin Clinic

Rome, Georgia, United States

RECRUITING

Outcomes

Primary Outcomes

Change in Western Ontario Rotator Cuff (WORC)

The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).

Time frame: Change from baseline to 3 months post-intervention

Secondary Outcomes

Western Ontario Rotator Cuff (WORC)

Time frame: Pre-op, 6 weeks, 3, 6, 12 and 24 months

Constant-Murley Score

The Constant-Murley Score is a validated assessment of pain and shoulder functionality. The Constant Score is divided into 4 subscales: pain (15 points; VAS score range of 0-15), activities of daily living (20 points; range 0=worst, 5=best), strength (25 points; 1 point given per 0.5 kg of weights raised), and range of motion - forward flexion, external rotation, abduction and internal rotation of the shoulder (40 points; range 0=worst, 10=best). The higher the score, the higher the quality of function.

Time frame: Pre-Op, 3, 6, 12 and 24 months

Central Contacts

Alice Kitching

CONTACT

+44 (0) 7590001182 alice.kitching@smith-nephew.com

Mary Ozokwere

CONTACT

+1 469-560-0727 Mary.Ozokwere@smith-nephew.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

OrthoIllinois LTD

Rockford, Illinois, United States

RECRUITING

Sinai Hospital Baltimore

Baltimore, Maryland, United States

WITHDRAWN

Cleveland Clinic - Sports Health

Garfield Heights, Ohio, United States

WITHDRAWN

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

RECRUITING

Texas Orthopedic Specialists

Bedford, Texas, United States

RECRUITING

Houston Methodist The Woodlands

The Woodlands, Texas, United States

WITHDRAWN

Memorial Medical Center

Ashland, Wisconsin, United States

WITHDRAWN

OrthoSport Victoria

Richmond, Victoria, Australia

RECRUITING

Access Orthopaedics

Calgary, Alberta, Canada

RECRUITING

...and 10 more locations

Subjective Shoulder Value (SSV) score

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Time frame: Pre-Op, 6 weeks, 3, 12 and 24 months

EuroQol 5 Dimension 5 Level (EQ-5D-5L) VAS & index scores

To assess the subject's health state. The EQ-5D-5L is composed of the EQ- 5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ- 5D-5L profile. The EQ VAS corresponds to a 20 cm vertical, visual analogue scale ranging from 'the best health you can imagine' to 'the worst health you can imagine'. A higher number is a better outcome.

Time frame: Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months

Change in Western Ontario Rotator Cuff (WORC)

Time frame: Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months

Change in Constant-Murley Score

Time frame: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

Change in Subjective Shoulder Value (SSV) score

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Time frame: Change from Pre-Op to 6 weeks, 3, 12 and 24 months

Percent Achieving Minimal Clinically Important Difference (MCID) for Constant-Murley Score

Time frame: Pre-Op, 3, 6, 12 and 24 months

Percent Achieving MCID for Western Ontario Rotator Cuff (WORC)

Time frame: Pre-op, 6 weeks, 3, 6, 12 and 24 months

Percent Achieving MCID for Subjective Shoulder Value (SSV) score

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100% (0% to 100% scale with 100% being normal).

Time frame: Pre-Op, 6 weeks, 3, 12 and 24 months

Patient Satisfaction

Comprise of 2 questions: 1. Overall, I am satisfied with the outcome of my surgery 2. I would recommend the procedure to a friend. Question rated by the patient with Strongly Agree, Agree, Neither Agree nor Disagree, Disagree, Strongly Disagree.

Time frame: 6 weeks, 3, 6, 12 and 24 months

Pain, Visual analog scale (VAS) Score

Pain is assessed on a 100-point scale ranging from 0 to 100, with zero (0) representing no pain and 100 representing the worst pain imaginable.

Time frame: Pre-Op, 3 and 6 weeks, 3, 12 and 24 months

MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Sugaya Score

The Sugaya score is classified into 5 categories: Type I to Type V. Type I indicates sufficient thickness with homogenously low intensity. Type II indicates sufficient thickness with partial high intensity. Type III indicates insufficient thickness without discontinuity. Type IV indicates presence of a minor discontinuity, suggesting a small full-thickness tear. Type V indicates the presence of a major discontinuity, suggesting a medium or large full-thickness tear.

Time frame: 12 months

MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of percent filling

Percent tissue infil is graded at site of original tear and classified as 0% to \< 25%, 25% to \< 50%, 50% to \< 75%, 75% to \< 100% and 100%.

Time frame: 12 months

MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via MRI assessment of the signal intensity pattern

The Signal Intensity Pattern will be graded into 3 categories. Type I: Heterogeneous high signal intensity with fluid-like bright foci, Type II: Heterogeneous high signal intensity without fluid-like bright foci, Type III: Heterogeneous or homogeneous low signal intensity.

Time frame: 12 months

MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Rotator cuff tendon thickness

Tendon thickness will be measured in millimeters (mm).

Time frame: 12 months

MRI Tendon Findings in subjects with Isolated Bioinductive Repair versus completion via Goutallier classification

The Goutallier classification will be used to classify the fatty infiltration of the rotator cuff. The Goutallier classification ranges from a grade of 0 indicating a completely normal muscles without any fatty streaks to a grade of 4 which indicates that more fat than muscle is present.

Time frame: 12 months

Incidence of Revision Surgery

Number of subjects requiring revision surgery

Time frame: 1, 3 and 6 weeks, 3, 6, 12 and 24 months

Time to return to work

Number of weeks taken to return to work following surgery

Time frame: Up to 24 months

Time to return to driving

Number of weeks taken to return to driving following surgery

Time frame: Up to 24 months

Time to return to sports

Number of weeks taken to return to sport following surgery

Time frame: Up to 24 months

Total operative time

Time expressed in minutes

Time frame: Inter-operative time

Physical Therapy Utilization

Number visits following index surgery

Time frame: Up to 24 months

Cumulative days of opioid use

Self-reported opioid use diary completed by the patient on a daily basis, from day 0-14, documenting opioid use. Consumption daily (YES/NO) x14 days, 'Have you taken any opioid medication today for shoulder pain?'

Time frame: Day 1-14

Duration of shoulder immobilization following index surgery

Number of days

Time frame: 1, 3 and 6 weeks, 3 months